Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Expert Opinion on Drug Metabolism & Toxicology|August 4, 2021
Cytotoxic activity of KRAS inhibitors in combination with chemotherapeuticsGerhard Hamilton, Adelina PlanggerExpert Opinion on Biological Therapy|March 12, 2019
Immunotherapy for small cell lung cancer: mechanisms of resistanceGerhard Hamilton, Barbara RathExpert Opinion on Drug Metabolism & Toxicology|December 12, 2017
Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1Gerhard Hamilton, Barbara RathExpert Opinion on Drug Metabolism & Toxicology|November 29, 2018
Applicability of tumor spheroids for in vitro chemosensitivity assaysGerhard Hamilton, Barbara RathWiener Medizinische Wochenschrift (1946)|September 25, 2014
A short update on cancer chemoresistanceGerhard Hamilton, Barbara RathExpert Opinion on Biological Therapy|July 8, 2021
Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapyGerhard Hamilton, Maryana TeufelsbauerExpert Opinion on Pharmacotherapy|April 4, 2022
Met inhibitors in the treatment of lung cancer: the evidence to dateGerhard Hamilton, Barbara RathBiologics : Targets & Therapy|July 15, 2021
The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and TherapyGerhard Hamilton, Adelina PlanggerTranslational Lung Cancer Research|September 15, 2017
Circulating tumor cell interactions with macrophages: implications for biology and treatmentGerhard Hamilton, Barbara RathExpert Opinion on Biological Therapy|March 10, 2017
Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicityGerhard Hamilton, Barbara RathPageof 10